Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: U01AI115940, U01AI069923
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Grant: Senior Fellowship
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Grant: Finance code 001
NIAID NIH HHS
Grant: U01 AI069923
NIAID NIH HHS
Grant: U01 AI115940
National Institutes of Health
Grant: 3U01AI069923-04S1
CCASAnet: Caribbean, Central and South America Network
National Institutes of Health
Grant: 5U01AI115940-04
Inflammatory determinants of disease severity and treatment outcome in TB patients
Ministério da Saúde
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals